Filed before 2025Filed 23 June 2020
Olema Pharmaceuticals, Inc. has sold $53.9M so far
Olema Pharmaceuticals, Inc., a pharmaceuticals company based in San Francisco, CA, has sold $53.9M so far in its equity round, according to a filing dated 23 June 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 23 June 2020
- First filed
- 27 March 2020
- Round
- Equity round (amended filing)
- Amount sold
- $53.9M
- Offering size
- $55.4M
- Investors so far
- 16
- Based in
- San Francisco, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 89% of the 1,744 tracked raises with an amount filed in 2020, and than 80% of the 40 in pharmaceuticals.
Olema Pharmaceuticals, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 13 Oct 2020 | New filing | $87.4M | Another raise |
| 23 Jun 2020 | Amended filing | $53.9M | This raise |
| 27 Mar 2020 | New filing | $30M | This raise |
More with Logos on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.